[Comparison of long-term clinical outcomes between transvaginal mesh and pelvic floor reconstruction with native tissue repair in the treatment of advanced pelvic organ prolapse].

医学 阴道 处女膜 子宫骶韧带 盆底 外科 围手术期 天然组织 子宫切除术 外科手术网 组织工程 生物医学工程
作者
Wu X,Yukui Zhang,Jiali Jiang,Yang Liu,Wenwen He,N Li,Kai Zhang,L Chen,Shifang Ren,Jianxiong Wu
出处
期刊:PubMed 卷期号:58 (8): 595-602
标识
DOI:10.3760/cma.j.cn112141-20230316-00123
摘要

Objective: To study the long-term clinical effect of transvaginal mesh (TVM) and pelvic floor reconstruction with native tissue repair (NTR) in the treatment of advanced pelvic organ prolapse (POP). Methods: Totally 207 patients with advanced POP who were treated in Hunan Provincial Maternal and Child Health Care Hospital from Jan. 2016 to Sep. 2019 were enrolled. The patient's pelvic organ prolapse quantification were all at degree Ⅲ or above, and they all complained for different degree of symptoms. They were divided into two groups according to the different surgical methods, TVM group and NTR group. In TVM group, the mesh was implanted through the vagina for pelvic floor reconstruction, while in NTR group, the traditional transvaginal hysterectomy combined with uterosacral ligament suspension and anterior and posterior wall repair, as well as perineal body repair were performed. The median follow-up time was 60 months, during the follow up time, 164 cases (79.2%, 164/207) had completed follow-up, including 76 cases in TVM group and 88 cases in NTR group. The perioperative data and complication rates of the two groups were compared, and the subjective and objective outcomes of the two groups at 1, 3 and 5 years were observed, respectively. The objective efficacy was evaluated by three composite criteria, namely: (1) the distance from the farthest end of the prolapse of the anterior and posterior wall of the vagina to the hymen is ≤0 cm, and the descending distance of the top is ≤1/2 of the total length of the vagina; (2) determine the disappearance of relevant POP symptoms according to "Do you often see or feel vaginal mass prolapse?"; (3) no further operation or pessary treatment was performed due to prolapse. If the above three criteria were met at the same time, the operation is successful; otherwise, it was recurrence. The subjective efficacy was evaluated by the pelvic floor distress inventory-short form 20 (PFDI-20) and pelvic floor impact questionnaire-short form 7 (PFIQ-7). Results: The median follow-up time of the two groups was 60 months (range: 41-82 months). Five years after the operation, the subjective and objective cure rates of TVM group were 89.5% (68/76) and 94.7% (72/76), respectively. The subjective and objective cure rates in NTR group were 80.7% (71/88) and 85.2% (75/88), respectively. There were significant differences in the subjective and objective cure rates between the two groups (χ2=9.869, P=0.002; χ2=3.969, P=0.046). The recurrence rate of TVM group was 5.3% (4/76), and that of NTR group was 14.8% (13/88). There was a significant difference between the two groups (P=0.046). The postoperative PFDI-20 and PFIQ-7 scores of the two groups were significantly lower than those before surgery, and there were significant differences of the two groups before and after surgery (all P<0.05). Postoperative mesh exposure in TVM group was 1.3% (1/76). Conclusions: The long-term outcomes between the two groups show that the subjective and objective outcomes of pelvic floor reconstruction in TVM group are significantly higher than those in NTR group, and the recurrence rate is significantly lower than that in NTR group. TVM has certain advantages in the treatment of advanced POP.目的: 比较经阴道植入网片盆底重建术(TVM)与自体组织盆底重建术(NTR)治疗重度盆腔器官脱垂(POP)的长期临床效果。 方法: 选取2016年1月至2019年9月在湖南省妇幼保健院诊治的207例重度POP患者,按盆腔器官脱垂定量(POP-Q)分度法分度均在Ⅲ度及以上,同时伴有临床症状。根据手术方法的不同分为TVM组和NTR组,TVM组为经阴道植入网片进行盆底重建术,NTR组则采用传统经阴道子宫切除加宫骶韧带悬吊加阴道前后壁和会阴体修补术。术后中位随访时间为60个月(范围:41~82个月),完成随访164例(79.2%,164/207),其中TVM组76例、NTR组88例。比较两组患者围手术期指标和并发症发生率,同时随访两组术后1、3、5年时的主、客观治疗效果。客观疗效采用手术成功的3项复合标准,即:(1)阴道前后壁脱垂最远端距离处女膜≤0 cm,同时顶端下降距离≤1/2阴道全长;(2)根据“经常看到或感到阴道有肿物脱出吗?”判定相关的POP症状消失;(3)未因脱垂而再行手术或子宫托治疗;同时满足以上3条标准者为手术成功(即客观治愈),反之为复发(术后3个月及以后)。主观疗效评价采用盆底不适调查表简表(PFDI-20)和盆底功能影响问卷简表(PFIQ-7)评分。 结果: 术后5年TVM组患者的主观、客观治愈率分别为89.5%(68/76)和94.7%(72/76),NTR组的主观、客观治愈率分别为80.7%(71/88)和85.2%(75/88),TVM组的主客观治愈率均显著高于NTR组,分别比较,差异均有统计学意义(χ2=9.869,P=0.002;χ2=3.969,P=0.046)。TVM组患者的复发率为5.3%(4/76),NTR组为14.8%(13/88),TVM组的复发率显著低于NTR组(P=0.046)。两组患者的术后PFDI-20和PFIQ-7评分均较术前明显降低(P均<0.05)。TVM组的网片暴露率为1.3%(1/76)。 结论: 本研究的TVM与NTR长期比较结果显示,TVM治疗重度POP的长期主客观疗效均显著优于NTR,复发率显著低于NTR,提示TVM对治疗重度POP有一定的优势。.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jintian完成签到 ,获得积分10
3秒前
胡杨树2006完成签到,获得积分10
12秒前
量子星尘发布了新的文献求助10
18秒前
坦率雪枫完成签到 ,获得积分10
21秒前
24秒前
嗯嗯完成签到 ,获得积分10
26秒前
28秒前
23333完成签到,获得积分10
28秒前
xxl3发布了新的文献求助10
30秒前
123完成签到 ,获得积分10
34秒前
风笛完成签到 ,获得积分10
40秒前
jason完成签到 ,获得积分10
42秒前
laber完成签到,获得积分0
44秒前
张来完成签到 ,获得积分10
46秒前
每天都要开心完成签到 ,获得积分10
51秒前
刘菠萝完成签到 ,获得积分10
53秒前
NexusExplorer应助zzt采纳,获得10
1分钟前
王海海完成签到 ,获得积分10
1分钟前
wonwojo完成签到 ,获得积分10
1分钟前
量子星尘发布了新的文献求助50
1分钟前
SciGPT应助xxl3采纳,获得10
1分钟前
Lrcx完成签到 ,获得积分10
1分钟前
QAQSS完成签到 ,获得积分10
1分钟前
星辰大海应助科研通管家采纳,获得10
1分钟前
科研通AI5应助科研通管家采纳,获得10
1分钟前
CJW完成签到 ,获得积分10
1分钟前
RYYYYYYY233完成签到 ,获得积分10
1分钟前
耕牛热完成签到,获得积分10
1分钟前
大团长完成签到,获得积分10
1分钟前
追寻夏烟完成签到 ,获得积分10
1分钟前
微笑代荷完成签到 ,获得积分10
1分钟前
好运来发布了新的文献求助10
1分钟前
汶南完成签到 ,获得积分10
1分钟前
lucky完成签到 ,获得积分10
1分钟前
朴素海亦完成签到 ,获得积分10
1分钟前
mengmenglv完成签到 ,获得积分0
2分钟前
荷戟执子手完成签到,获得积分10
2分钟前
量子星尘发布了新的文献求助10
2分钟前
2分钟前
奥丁不言语完成签到 ,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Zeolites: From Fundamentals to Emerging Applications 1500
Architectural Corrosion and Critical Infrastructure 1000
Early Devonian echinoderms from Victoria (Rhombifera, Blastoidea and Ophiocistioidea) 1000
Hidden Generalizations Phonological Opacity in Optimality Theory 1000
2026国自然单细胞多组学大红书申报宝典 800
Real Analysis Theory of Measure and Integration 3rd Edition 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4910669
求助须知:如何正确求助?哪些是违规求助? 4186400
关于积分的说明 12999449
捐赠科研通 3953919
什么是DOI,文献DOI怎么找? 2168175
邀请新用户注册赠送积分活动 1186604
关于科研通互助平台的介绍 1093837